Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors

被引：0
|
作者：
Matthew E. Hardee
Rose J. Eapen
Zahid N. Rabbani
Matthew R. Dreher
Jeffrey Marks
Kimberly L. Blackwell
Mark W. Dewhirst
机构：
[1] Duke University Medical Center,Department of Pathology
[2] University of North Carolina Medical Center,Department of Otolaryngology
[3] Duke University Medical Center,Department of Radiation Oncology
[4] National Institutes of Health Clinical Center,Department of Diagnostic Radiology
[5] Duke University Medical Center,Department of Surgery
[6] Duke University Medical Center,Department of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 63卷
关键词：
Her2/neu; Angiogenesis; Tumor hypoxia; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：219 / 228
页数：9
相关论文
共 50 条
  • [1] Her2/neu signaling blockade improves tumor oxygenation in a multifactorial fashion in Her2/neu+ tumors
    Hardee, Matthew E.
    Eapen, Rose J.
    Rabbani, Zahid N.
    Dreher, Matthew R.
    Marks, Jeffrey
    Blackwell, Kimberly L.
    Dewhirst, Mark W.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 219 - 228
  • [2] DCIS and HER2/neu
    Tulusan, AH
    ONKOLOGIE, 2002, 25 : 11 - 12
  • [3] HER2/neu expression in malignant lung tumors
    Hirsch, FR
    Franklin, WA
    Veve, R
    Varella-Garcia, M
    Bunn, PA
    SEMINARS IN ONCOLOGY, 2002, 29 (01) : 51 - 58
  • [4] Phosphoproteomic analysis of Her2/neu signaling and inhibition
    Bose, Ron
    Molina, Henrik
    Patterson, A. Scott
    Bitok, John K.
    Periaswamy, Balamurugan
    Bader, Joel S.
    Pandey, Akhilesh
    Cole, Philip A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) : 9773 - 9778
  • [5] Phosphoproteomic analysis of Her2/neu signaling and inhibition
    Bose, Ron
    Molina, Henrik
    Bitok, John K.
    Bader, Joel S.
    Pandey, Akhilesh
    Cole, Philip A.
    CANCER RESEARCH, 2006, 66 (08)
  • [6] Serum HER2/neu levels in breast cancer patients with different level of tumor HER2/neu protein expression
    Kushlinsky, Nicolai
    Gershtein, Elena
    Shyroky, Vyacheslav
    Ermilova, Valeriya
    Tchemeris, Galina
    Letyagin, Victor
    TUMOR BIOLOGY, 2007, 28 : 95 - 95
  • [7] Role of HER2/neu in tumor progession and therapy
    Ménard, S
    Casalini, P
    Campiglio, M
    Pupa, SM
    Tagliabue, E
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (23) : 2965 - 2978
  • [8] Activating Mutations in HER2: Neu Opportunities and Neu Challenges
    Weigelt, Britta
    Reis-Filho, Jorge S.
    CANCER DISCOVERY, 2013, 3 (02) : 145 - 147
  • [9] A novel nanobioconjugate for the treatment of HER2/neu expressing tumors
    Helguera, Gustavo
    Rodriguez, Jose
    Ding, Hui
    Inoue, Satoshi
    Patil, Rameshawar
    Holler, Eggehard
    Black, Keith
    Ljubimova, Julia
    Penichet, Manuel
    CANCER RESEARCH, 2009, 69
  • [10] Dysregulation of cellular signaling by HER2/neu in breast cancer
    Zhou, BP
    Hung, MC
    SEMINARS IN ONCOLOGY, 2003, 30 (05) : 38 - 48
12345